Clinical trial

A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA

NCT04291937

Study summary

ClinicalTrials.gov

A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA

Design: EXPANDED_ACCESS · Status: APPROVED FOR MARKETING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Lurbinectedin Normalized identity: lurbinectedin View linked drug · Find medicine records · Find other trials using this name

StatusAPPROVED_FOR_MARKETING

Study typeEXPANDED_ACCESS

Start dateUnknown

PhaseN/A

Conditions

Small Cell Lung Cancerverified · MONDO: small cell lung carcinoma

Interventions

LurbinectedinDRUG · verified · RxNorm: lurbinectedin

Sponsors & collaborators

Jazz Pharmaceuticalslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04291937 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.